The store will not work correctly when cookies are disabled.
9-benzyl-2-(2-methoxyethoxy)-6-(methylamino)-7H-purin-8(9H)-one
ID: ALA4763327
PubChem CID: 118704898
Max Phase: Preclinical
Molecular Formula: C16H19N5O3
Molecular Weight: 329.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CNc1nc(OCCOC)nc2c1[nH]c(=O)n2Cc1ccccc1
Standard InChI: InChI=1S/C16H19N5O3/c1-17-13-12-14(20-15(19-13)24-9-8-23-2)21(16(22)18-12)10-11-6-4-3-5-7-11/h3-7H,8-10H2,1-2H3,(H,18,22)(H,17,19,20)
Standard InChI Key: OSILWVXKFRDCIL-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
15.0919 -3.2852 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0907 -4.1048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7988 -4.5137 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7970 -2.8764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5056 -3.2816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5104 -4.1002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2904 -4.3487 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7678 -3.6836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2827 -3.0242 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.5850 -3.6788 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.7945 -2.0592 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.5475 -5.1244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3478 -5.2897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5996 -6.0654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3991 -6.2309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9432 -5.6200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6824 -4.8411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8835 -4.6794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3827 -4.5128 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6753 -4.1037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9673 -4.5117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2599 -4.1025 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5518 -4.5106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5010 -1.6485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
8 10 2 0
4 11 1 0
7 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
2 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
11 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 329.36 | Molecular Weight (Monoisotopic): 329.1488 | AlogP: 1.23 | #Rotatable Bonds: 7 |
Polar Surface Area: 94.06 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.31 | CX Basic pKa: 2.68 | CX LogP: 2.13 | CX LogD: 2.13 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.63 | Np Likeness Score: -1.17 |
References
1. Kettle JG,Alwan H,Bista M,Breed J,Davies NL,Eckersley K,Fillery S,Foote KM,Goodwin L,Jones DR,Käck H,Lau A,Nissink JW,Read J,Scott JS,Taylor B,Walker G,Wissler L,Wylot M. (2016) Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival., 59 (6): [PMID:26878898] [10.1021/acs.jmedchem.5b01760] |